Frontiers in Oncology (Jun 2023)
Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy
- Yulong Fu,
- Yulong Fu,
- Anqi Wang,
- Anqi Wang,
- Jieqi Zhou,
- Jieqi Zhou,
- Wei Feng,
- Minhua Shi,
- Xiao Xu,
- Hongqing Zhao,
- Liming Cai,
- Jian Feng,
- Xuedong Lv,
- Xiaodong Zhang,
- Wenjing Xu,
- Zhengrong Zhang,
- Guoer Ma,
- Jian Wang,
- Tong Zhou,
- Dahai Zhao,
- Haohui Fang,
- Zeyi Liu,
- Zeyi Liu,
- Zeyi Liu,
- Jian-an Huang,
- Jian-an Huang,
- Jian-an Huang
Affiliations
- Yulong Fu
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
- Yulong Fu
- Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China
- Anqi Wang
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
- Anqi Wang
- Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China
- Jieqi Zhou
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
- Jieqi Zhou
- Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China
- Wei Feng
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
- Minhua Shi
- Department of Respiratory Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China
- Xiao Xu
- Department of Respiratory Medicine, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
- Hongqing Zhao
- Department of Respirology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, China
- Liming Cai
- Department of Respiratory Medicine, Affiliated Hospital of Jiangnan University, Wuxi, China
- Jian Feng
- Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong, China
- Xuedong Lv
- Department of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China
- Xiaodong Zhang
- Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China
- Wenjing Xu
- 0Departments of Respiratory Medicine, Northern Jiangsu People’s Hospital, Clinical Medical College of Yangzhou University, Yangzhou, China
- Zhengrong Zhang
- 1Department of Respiratory Medicine, First People’s Hospital of Yangzhou City, Yangzhou, China
- Guoer Ma
- 2Department of Respiratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China
- Jian Wang
- 3Department of Respiratory Medicine, Zhenjiang First People’s Hospital, Zhenjiang, China
- Tong Zhou
- 4Department of Oncology, Changzhou Cancer Hospital Affiliated to Soochow University, Changzhou, China
- Dahai Zhao
- 5Department of Respiratory and Critical Care Medicine, The Second Hospital of Anhui Medical University, Hefei, China
- Haohui Fang
- 6Department of Respiratory Medicine, Anhui Chest Hospital, Hefei, China
- Zeyi Liu
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
- Zeyi Liu
- Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China
- Zeyi Liu
- 7Institute of Respiratory Diseases, Soochow University, Suzhou, China
- Jian-an Huang
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
- Jian-an Huang
- Suzhou Key Laboratory for Respiratory Diseases, Suzhou, China
- Jian-an Huang
- 7Institute of Respiratory Diseases, Soochow University, Suzhou, China
- DOI
- https://doi.org/10.3389/fonc.2023.1236311
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- non-small cell lung cancer
- liquid biopsy
- gene sequencing
- epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)
- drug resistance
